The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study

Published:2020-05 Issue:5 Volume:21 Page:264-271
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J Dig Dis

Author:

Glassner Kerri¹^ORCID,Oglat Ayah²,Duran Antonio³,Koduru Pramoda⁴,Perry Caroline¹,Wilhite Amanda¹,Abraham Bincy P.¹

Affiliation:

1. Division of GastroenterologyHouston Methodist Hospital Houston Texas USA

2. Division of GastroenterologyVidant Medical Center Greenville North Carolina USA

3. Division of CardiologyOchsner Medical Center New Orleans Louisiana USA

4. Digestive Disease Specialists, Inc Oklahoma City Oklahoma USA

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12867

Reference20 articles.

1. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

2. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

3. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

4. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update;Inflammatory Bowel Diseases;2024-08-29

2. Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report;World Journal of Clinical Cases;2024-08-16

3. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06

4. Combination treatment of inflammatory bowel disease: Present status and future perspectives;World Journal of Gastroenterology;2024-04-21

5. Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel disease;Mucosal Immunology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3